
societyAug 20, 20261:23:56pending
Longevity: Hope, Hype, and Science with Dr . Bill Lawrence
About this episode
What does it truly mean to live longer—and how can we separate promising longevity science from exaggerated claims? In this episode of the Ageless and Timeless Podcast, Michele Hughes welcomes back longevity researcher and biogerontology scientist Bill Lawrence, PhD, for an evidence-focused exploration of biological aging, healthspan, and peptide bioregulators. Dr. Lawrence explains the important distinctions between lifespan, healthspan, and biological longevity. He also discusses how researchers use biomarkers such as telomere length, epigenetic testing, pace of aging, and organ-specific biological age to evaluate potential longevity interventions. Drawing upon his work with the scientific legacy of Professor Vladimir Khavinson, Dr. Lawrence introduces Khavinson Peptide Bioregulators—short, organ-specific regulatory peptides studied for their potential influence on gene expression, cellular repair, and age-related functional decline. He explains how these compounds differ from popular synthetic peptides and why the two categories may serve very different purposes. The conversation also examines the evidence behind today’s most talked-about longevity interventions. Dr. Lawrence separates approaches that may improve general health or reduce disease risk from those he believes meet a more rigorous standard for influencing biological aging. Michele and Dr. Lawrence Discuss
- The difference between lifespan, healthspan, and biological longevity
- Why Americans may spend so many of their later years managing chronic illness
- The importance of published research and measurable biomarkers
- How telomeres and epigenetic clocks are used to estimate biological aging
- How organ-specific biological age testing can help identify accelerated aging
- The difference between peptide bioregulators and synthetic therapeutic peptides
- Why synthetic peptides may be better suited to short-term or acute needs
- The long-term, regenerative focus of peptide bioregulators
- Professor Vladimir Khavinson’s research into pineal and thymus peptides
- The Hayflick limit and the role of cellular replication in aging
- Research examining peptides, mortality risk, and age-related functional decline
- Studies involving peptide bioregulators and vision-related conditions
- How personalized peptide protocols may be developed using biological-age testing
- Dr. Lawrence’s ongoing biological-age interventional studies
Get every episode summarized
Each time Ageless and Timeless Podcast® publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Ageless and Timeless Podcast®

Del Bigtree on Purpose, Personal Practices and His Public Career
Ageless and Timeless Podcast®
Aug 4, 20261:04:11pending

The Science of Skin Longevity: Botanicals, Fascia & Cellular Health
Ageless and Timeless Podcast®
Jul 22, 20261:15:49pending

Decoding Your DNA: The Personalized Path to Better Health with Kim Ressler
Ageless and Timeless Podcast®
Jun 25, 20261:09:10pending

Functional Medicine, Aesthetics & Longevity with Dominika Laureto
Ageless and Timeless Podcast®
Jun 1, 20261:01:29pending